Latest On Nabriva Therapeutics plc (NBRV):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-02-06 20:31 EST | News | Merck, Nabriva terminate distribution agreement for antibacterial | N/A |  |
| 2022-11-28 15:18 EST | News | Nabriva Therapeutics rallies on positive topline results from Phase 1 trial of XENLETA | N/A | |
| 2022-11-28 15:18 EST | News | Nabriva gains after announcing Phase 1 data for cystic fibrosis candidate | N/A | |
| 2022-11-13 20:22 EST | News | Nabriva Therapeutics plc (NBRV) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 20:37 EST | News | Nabriva Therapeutics GAAP EPS of -$4.21 misses by $0.18, revenue of $9.15M misses by $1.53M | N/A | |
| 2022-09-15 19:36 EST | News | Nabriva Therapeutics to effect 1-for-25 reverse stock split | N/A | |
| 2022-08-03 23:50 EST | News | Nabriva Therapeutics GAAP EPS of -$0.18 beats by $0.02, revenue of $9.19M beats by $0.66M | N/A | |
| 2022-08-03 23:49 EST | News | Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-02 18:40 EST | News | Nabriva Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-18 15:38 EST | News | Nabriva stock soars 19% on distribution deal with Er-Kim for bacterial pneumonia drug Xenleta | N/A | |
| 2022-05-08 19:47 EST | News | Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 05:36 EST | News | Nabriva extends exclusive contract to sell Merck's antibacterial drug Sivextro in US | N/A | |
| 2022-05-06 05:35 EST | News | Nabriva Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $8.02M misses by $1.55M | N/A | |
| 2022-05-05 06:42 EST | News | Nabriva Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-03-30 21:27 EST | News | Northland Securities slashes Nabriva Therapeutics' price target | N/A | |
| 2022-03-30 04:50 EST | News | Nabriva Therapeutics GAAP EPS of -$0.24, revenue of $9.26M | N/A | |
| 2022-03-30 04:50 EST | News | Nabriva 4Q results indicate slowdown in topline growth | N/A | |
| 2022-03-30 04:50 EST | News | Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-30 04:50 EST | News | Nabriva Therapeutics plc 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-29 05:59 EST | News | Nabriva Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2021-11-29 11:43 EST | News | Nabriva Therapeutics' lefamulin application accepted for review in China | N/A | |
| 2021-11-10 12:36 EST | News | Nabriva Therapeutics EPS beats by $0.01, beats on revenue | N/A | |
| 2021-11-10 12:35 EST | News | Nabriva Therapeutics plc (NBRV) CEO Theodore Schroeder on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 12:35 EST | News | Nabriva Therapeutics plc 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-09 13:31 EST | News | Nabriva Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-11-02 00:54 EST | News | Nabriva Therapeutics reports inducement grant to CMO | N/A | |
| 2021-10-01 18:21 EST | News | Nabriva Therapeutics hires Chief Medical Officer | N/A | |
| 2021-09-10 05:07 EST | News | Nabriva inks deal to make Xenleta available to Vizient’s pharmacy network program | N/A | |
| 2021-09-08 12:54 EST | News | Nabriva shares rise after Xenleta approval in Taiwan | N/A | |
| 2021-08-10 08:20 EST | News | Nabriva Therapeutics plc 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-07 03:49 EST | News | Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-06 07:28 EST | News | Nabriva Therapeutics EPS beats by $0.06, beats on revenue | N/A | |
| 2021-07-21 16:58 EST | News | Nabriva antibiotic meets primary endpoint in phase 3 trial; shares soar 40% | N/A | |
| 2021-07-21 16:54 EST | News | Nabriva Therapeutics extends principal debt repayments leading to cash runway extension | N/A | |
| 2021-05-07 12:24 EST | News | Nabriva Therapeutics EPS beats by $0.14, beats on revenue | N/A | |
| 2021-04-15 23:22 EST | News | Nabriva commences exclusive distribution of SIVEXTRO in the U.S. | N/A | |
| 2021-03-16 21:29 EST | Analyst Rating | The Analyst Target Price has decreased from $9 to $6. | Neutral | |
| 2021-03-12 08:10 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-12 07:50 EST | News | Nabriva Therapeutics EPS misses by $0.33, beats on revenue | N/A | |
| 2021-03-12 07:49 EST | News | Nabriva Therapeutics PLC (NBRV) CEO Theodore Schroeder on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-12 04:16 EST | Earnings Estimate | An EPS average of -$1.77 is estimated for the 2022 year. | Sell | |
| 2021-03-12 04:16 EST | Earnings Estimate | An EPS average of -$0.70 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-01 21:18 EST | News | Nabriva Therapeutics under pressure on $25.4M registered direct offering | N/A | |
| 2021-02-26 23:01 EST | News | Nabriva names Daniel Dolan CFO | N/A | |
| 2021-02-01 17:16 EST | News | Nabriva Therapeutics announces CFO retirement | N/A | |
| 2021-01-06 16:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-11 12:14 EST | Analyst Rating | The Analyst Target Price has decreased from $14.5 to $9. | Neutral | |
| 2020-12-11 09:20 EST | News | Nabriva Therapeutics prices $15M public offering | N/A | |
| 2020-12-08 12:25 EST | Analyst Rating | The Analyst Target Price has decreased from $17.5 to $14.5. | Neutral | |
| 2020-12-08 08:59 EST | News | Nabriva Therapeutics shares gain as Sinovant expands Xenleta support in China | N/A | |
About Nabriva Therapeutics plc (NBRV):
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia; and SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI). It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.
General
- Name Nabriva Therapeutics plc
- Symbol NBRV
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 72
- Last Split Factor1:10
- Last Split Date2020-12-03
- Fiscal Year EndDecember
- IPO Date2015-09-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.nabriva.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 26.22
- Price/Book (Most Recent Quarter) 1.52
- Enterprise Value Revenue 20.07
- Enterprise Value EBITDA 0.04
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.02
- Next Year EPS Estimate -$1.17
- Operating Margin -1315%
- Return on Assets -54%
- Return on Equity -187%
- Revenue 5.03 million
- Earnings Per Share -$1.88
- Revenue Per Share $0.39
- Gross Profit -10841000
- Quarterly Earnings Growth 638.7%
View More
Highlights
- Market Capitalization 73.26 million
- EBITDA -91483000
- PEG Ratio -0.06
- Analyst Target Price $6
- Book Value Per Share $1.57
View More
Share Statistics
- Shares Outstanding 34.79 million
- Shares Float 24.75 million
- % Held by Insiders 45%
- % Held by Institutions 20.73%
- Shares Short 1.62 million
- Shares Short Prior Month 1.28 million
- Short Ratio 1.08
- Short % of Float 6%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 1.9
- 52 Week High $12
- 52 Week Low $1.52
- 50 Day Moving Average 2.5
- 200 Day Moving Average 3.91
View More
Dividends
- Dividend Date 2020-12-03
- ExDividend Date N/A
- Dividend Yield 0%
View More
Nabriva Therapeutics plc (NBRV) Dividend Calendar:
NBRV's last dividend payment was made to shareholders on December 3, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Nabriva Therapeutics plc (NBRV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-11 | $2.46 million | -$1.11 | -$0.94 | -18.09% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.90 | -$0.98 | 7.69% |
| 2020-06-30 | 2020-08-06 | $N/A | -$1.40 | -$1.60 | 12.5% |
| 2020-03-31 | 2020-05-11 | $301000 | -$2.17 | -$2.55 | 15.01% |
| 2019-12-31 | 2020-03-12 | $333000 | -$2.90 | -$3.45 | 15.94% |
| 2019-09-30 | 2019-11-12 | $6.92 million | -$2.40 | -$3.07 | 21.74% |
| 2019-06-30 | 2019-08-08 | $525000 | -$3.00 | -$3.37 | 10.89% |
| 2019-03-31 | 2019-05-10 | $1.7 million | -$2.90 | -$3.30 | 12.12% |
| 2018-12-31 | 2019-03-12 | $797000 | -$4.10 | -$3.15 | -30.16% |
| 2018-09-30 | 2018-11-06 | $461000 | -$9.00 | -$3.30 | -172.73% |
| 2018-06-30 | 2018-08-09 | $847000 | -$4.40 | -$5.00 | 12% |
| 2018-03-31 | 2018-05-08 | $7.55 million | -$3.60 | -$5.70 | 36.84% |
| 2017-12-31 | 2018-03-16 | $1.12 million | -$6.00 | -$5.80 | -3.45% |
| 2017-09-30 | 2017-11-09 | $1.47 million | -$7.90 | -$5.93 | -33.33% |
| 2017-06-30 | 2017-08-07 | $1.05 million | -$5.40 | -$5.50 | 1.82% |
| 2017-03-31 | 2017-05-10 | $1.68 million | -$0.56 | -$5.48 | 89.78% |
| 2016-12-31 | 2017-03-24 | $2.31 million | -$0.69 | -$0.57 | -21.05% |
| 2016-09-30 | 2016-11-16 | $971000 | -$0.66 | -$2.53 | 73.91% |
| 2016-06-30 | 2016-08-09 | $1.79 million | -$0.56 | -$5.64 | 90.07% |
| 2016-03-31 | 2016-04-27 | $1.42 million | -$0.66 | -$0.76 | 13.16% |
| 2015-09-30 | 2015-11-10 | $N/A | -$0.18 |
Nabriva Therapeutics plc (NBRV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 172000 | N/A | N/A | 4.94 million | 5.2 million |
| Income Before Tax | -17.89 million | N/A | N/A | -23.11 million | -23.02 million |
| Selling General Administrative | 20.19 million | N/A | N/A | 16.03 million | 17.15 million |
| Gross Profit | 2.1 million | N/A | N/A | 293000 | 278000 |
| Ebit | -17.69 million | N/A | N/A | -21.97 million | -22.07 million |
| Operating Income | -18.27 million | N/A | N/A | -20.19 million | -22.07 million |
| Income Tax Expense | -60000 | -72000 | 119000 | N/A | 21000 |
| Total Revenue | 2.46 million | N/A | N/A | 301000 | 333000 |
| Cost of Revenue | 365000 | N/A | N/A | 8000 | 55000 |
| Total Other Income Expense Net | N/A | N/A | N/A | -1.96 million | -954000 |
| Net Income From Continuing Operations | -17.83 million | N/A | N/A | -23.26 million | -23.05 million |
| Net Income Applicable to Common Shares | -17.83 million | -12.95 million | -15.44 million | N/A | -23.05 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -228000 | -20000 | N/A | 15 million |
| Change to Liabilities | -579000 | N/A | N/A | 39000 | 307000 |
| Total Cash Flow from Investing Activities | -9000 | N/A | N/A | 200000 | 15.19 million |
| Net Borrowings | N/A | N/A | N/A | -9.98 million | 9.9 million |
| Total Cash Flow from Financial Activities | N/A | 39.39 million | -30.22 million | 23.4 million | 19.25 million |
| Change to Operating Activities | 163000 | N/A | N/A | 3.93 million | 511000 |
| Change in Cash | N/A | 22.51 million | -59.03 million | 8.08 million | 19.66 million |
| Total Cash from Operating Activities | -12.6 million | -17.26 million | -28.11 million | -15.49 million | -14.66 million |
| Depreciation | N/A | 262000 | 118000 | -453000 | -3000 |
| Other Cash Flow from Investing Activities | 1000 | N/A | N/A | 103000 | 228000 |
| Change to Inventory | N/A | -972000 | -3.54 million | 162000 | -162000 |
| Change to Account Receivables | N/A | N/A | N/A | 1.26 million | -1.65 million |
| Other Cash Flow from Financing Activities | -361000 | N/A | N/A | 56.73 million | -245000 |
| Change to Net Income | 1.19 million | N/A | N/A | 2.66 million | 4.11 million |
| Capital Expenditures | N/A | 13000 | 72000 | 97000 | 40000 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 25.3 million | N/A | N/A | 21.09 million | 52.84 million |
| Total Stockholder Equity | 33.14 million | N/A | N/A | 19.91 million | 41.27 million |
| Other Current Liabilities | 750000 | N/A | N/A | 2.28 million | N/A |
| Total Assets | 58.44 million | N/A | N/A | 41 million | 94.11 million |
| Common Stock | 211000 | 1.5 million | 1.43 million | N/A | 945000 |
| Other Current Assets | 5.88 million | 230000 | N/A | N/A | 392000 |
| Retained Earnings | -546.23 million | -528.39 million | -515.44 million | -500 million | -476.74 million |
| Other Liabilities | N/A | 1.96 million | 2.12 million | N/A | 1.7 million |
| Other Assets | N/A | 369000 | 368000 | N/A | 378000 |
| Cash | 41.59 million | N/A | N/A | 26.94 million | 86.02 million |
| Total Current Liabilities | 18.52 million | 10.98 million | N/A | 11.96 million | 16.64 million |
| Other Stockholder Equity | 27000 | 27000 | 27000 | N/A | 27000 |
| Property, Plant & Equipment | 768000 | 2.01 million | 2.18 million | N/A | 2.47 million |
| Total Current Assets | 57.22 million | 54.31 million | N/A | 38.17 million | 91.17 million |
| Long Term Investments | 370000 | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 33.06 million | 36.15 million | 44.36 million | N/A | 41.18 million |
| Short Term Investments | 16000 | N/A | N/A | 175000 | 175000 |
| Long Term Debt | 5.69 million | N/A | N/A | 7.37 million | 34.5 million |
| Inventory | 5.82 million | 5.8 million | N/A | 4.22 million | 682000 |
| Accounts Payable | 15.73 million | 2.04 million | N/A | 2.03 million | 4.67 million |
Nabriva Therapeutics plc (NBRV) Chart:
Nabriva Therapeutics plc (NBRV) News:
Below you will find a list of latest news for Nabriva Therapeutics plc (NBRV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Nabriva Therapeutics plc (NBRV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest NBRV Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 3:15 PM EST | 540 | $0.2 |
Nabriva Therapeutics plc (NBRV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080578/0001104659-20-080578-index.htm |
| 2020-09-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1641640/000000000020008431/0000000000-20-008431-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000031506620001103/0000315066-20-001103-index.htm |
| 2018-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000090221918000484/0000902219-18-000484-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000090221919000015/0000902219-19-000015-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000090221919000021/0000902219-19-000021-index.htm |
| 2019-12-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1641640/000094787119000896/0000947871-19-000896-index.htm |
| 2019-12-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1641640/000094787119000987/0000947871-19-000987-index.htm |
| 2018-09-10 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1641640/000104746918006094/0001047469-18-006094-index.htm |
| 2018-10-01 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1641640/000104746918006504/0001047469-18-006504-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1641640/000104746919001138/0001047469-19-001138-index.htm |
| 2019-06-14 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1641640/000104746919003649/0001047469-19-003649-index.htm |
| 2019-06-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1641640/000104746919003866/0001047469-19-003866-index.htm |
| 2019-12-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1641640/000104746919006929/0001047469-19-006929-index.htm |
| 2020-06-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1641640/000104746920003278/0001047469-20-003278-index.htm |
| 2020-06-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1641640/000104746920003282/0001047469-20-003282-index.htm |
| 2020-06-12 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1641640/000104746920003566/0001047469-20-003566-index.htm |
| 2020-06-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1641640/000104746920003859/0001047469-20-003859-index.htm |
| 2020-09-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1641640/000104746920004734/0001047469-20-004734-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000107261319000088/0001072613-19-000088-index.htm |
| 2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465918049250/0001104659-18-049250-index.htm |
| 2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465918049251/0001104659-18-049251-index.htm |
| 2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465918049252/0001104659-18-049252-index.htm |
| 2018-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465918049576/0001104659-18-049576-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465918050163/0001104659-18-050163-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465918050795/0001104659-18-050795-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000110465918050835/0001104659-18-050835-index.htm |
| 2018-09-10 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465918056032/0001104659-18-056032-index.htm |
| 2018-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465918065105/0001104659-18-065105-index.htm |
| 2018-10-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1641640/000110465918065109/0001104659-18-065109-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465918066192/0001104659-18-066192-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000110465918066303/0001104659-18-066303-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465918074266/0001104659-18-074266-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465918074905/0001104659-18-074905-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919000791/0001104659-19-000791-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919001838/0001104659-19-001838-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919005516/0001104659-19-005516-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919005519/0001104659-19-005519-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919005520/0001104659-19-005520-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919005521/0001104659-19-005521-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919005522/0001104659-19-005522-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919005523/0001104659-19-005523-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000110465919008799/0001104659-19-008799-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919009191/0001104659-19-009191-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919014080/0001104659-19-014080-index.htm |
| 2019-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1641640/000110465919014287/0001104659-19-014287-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919018855/0001104659-19-018855-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919025701/0001104659-19-025701-index.htm |
| 2019-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919028448/0001104659-19-028448-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000110465919028565/0001104659-19-028565-index.htm |
| 2019-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919036587/0001104659-19-036587-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919037436/0001104659-19-037436-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919041742/0001104659-19-041742-index.htm |
| 2019-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919041878/0001104659-19-041878-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043340/0001104659-19-043340-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043342/0001104659-19-043342-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043343/0001104659-19-043343-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043344/0001104659-19-043344-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043345/0001104659-19-043345-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043346/0001104659-19-043346-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043347/0001104659-19-043347-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919043927/0001104659-19-043927-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919044731/0001104659-19-044731-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000110465919044881/0001104659-19-044881-index.htm |
| 2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046525/0001104659-19-046525-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046854/0001104659-19-046854-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046855/0001104659-19-046855-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046856/0001104659-19-046856-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046857/0001104659-19-046857-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046858/0001104659-19-046858-index.htm |
| 2019-08-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047347/0001104659-19-047347-index.htm |
| 2019-08-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047348/0001104659-19-047348-index.htm |
| 2019-08-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047349/0001104659-19-047349-index.htm |
| 2019-08-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047350/0001104659-19-047350-index.htm |
| 2019-08-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047351/0001104659-19-047351-index.htm |
| 2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047352/0001104659-19-047352-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047723/0001104659-19-047723-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465919048436/0001104659-19-048436-index.htm |
| 2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919049328/0001104659-19-049328-index.htm |
| 2019-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919051550/0001104659-19-051550-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919062629/0001104659-19-062629-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919074617/0001104659-19-074617-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919074693/0001104659-19-074693-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465919075598/0001104659-19-075598-index.htm |
| 2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920002277/0001104659-20-002277-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920010896/0001104659-20-010896-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920010897/0001104659-20-010897-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920010899/0001104659-20-010899-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920010900/0001104659-20-010900-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920010901/0001104659-20-010901-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920010902/0001104659-20-010902-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015171/0001104659-20-015171-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015172/0001104659-20-015172-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015173/0001104659-20-015173-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015174/0001104659-20-015174-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015176/0001104659-20-015176-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015178/0001104659-20-015178-index.htm |
| 2020-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920019213/0001104659-20-019213-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920028847/0001104659-20-028847-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920028848/0001104659-20-028848-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920028849/0001104659-20-028849-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920028850/0001104659-20-028850-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920028851/0001104659-20-028851-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920028852/0001104659-20-028852-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920032466/0001104659-20-032466-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920042578/0001104659-20-042578-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920042579/0001104659-20-042579-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920042580/0001104659-20-042580-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920042581/0001104659-20-042581-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920042582/0001104659-20-042582-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920042583/0001104659-20-042583-index.htm |
| 2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920044193/0001104659-20-044193-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920055666/0001104659-20-055666-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920056348/0001104659-20-056348-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920056349/0001104659-20-056349-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920056350/0001104659-20-056350-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920056351/0001104659-20-056351-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920056352/0001104659-20-056352-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920056355/0001104659-20-056355-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920059553/0001104659-20-059553-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920066371/0001104659-20-066371-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920067379/0001104659-20-067379-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920067962/0001104659-20-067962-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920069178/0001104659-20-069178-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920069179/0001104659-20-069179-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920069180/0001104659-20-069180-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920069182/0001104659-20-069182-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920069184/0001104659-20-069184-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920069188/0001104659-20-069188-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920075453/0001104659-20-075453-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080539/0001104659-20-080539-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080540/0001104659-20-080540-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080541/0001104659-20-080541-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080542/0001104659-20-080542-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080544/0001104659-20-080544-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920080578/0001104659-20-080578-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920083753/0001104659-20-083753-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920087993/0001104659-20-087993-index.htm |
| 2020-07-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1641640/000110465920087999/0001104659-20-087999-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089136/0001104659-20-089136-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089139/0001104659-20-089139-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089140/0001104659-20-089140-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089141/0001104659-20-089141-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089143/0001104659-20-089143-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089144/0001104659-20-089144-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920090278/0001104659-20-090278-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920090281/0001104659-20-090281-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920090282/0001104659-20-090282-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920090283/0001104659-20-090283-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920090332/0001104659-20-090332-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920090334/0001104659-20-090334-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097716/0001104659-20-097716-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097717/0001104659-20-097717-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097718/0001104659-20-097718-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097719/0001104659-20-097719-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097720/0001104659-20-097720-index.htm |
| 2020-09-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101436/0001104659-20-101436-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101445/0001104659-20-101445-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101903/0001104659-20-101903-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101905/0001104659-20-101905-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101906/0001104659-20-101906-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101907/0001104659-20-101907-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101908/0001104659-20-101908-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920101909/0001104659-20-101909-index.htm |
| 2020-09-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1641640/000110465920103455/0001104659-20-103455-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920111074/0001104659-20-111074-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920111075/0001104659-20-111075-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920111076/0001104659-20-111076-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920111077/0001104659-20-111077-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920111079/0001104659-20-111079-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920111080/0001104659-20-111080-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920120638/0001104659-20-120638-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920120639/0001104659-20-120639-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920120640/0001104659-20-120640-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920120641/0001104659-20-120641-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1641640/000110465920120642/0001104659-20-120642-index.htm |
| 2018-08-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000114420418042472/0001144204-18-042472-index.htm |
| 2018-08-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000119312518236943/0001193125-18-236943-index.htm |
| 2019-02-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000119312519025367/0001193125-19-025367-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000119312519040450/0001193125-19-040450-index.htm |
| 2019-07-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000119312519187447/0001193125-19-187447-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000119312520033287/0001193125-20-033287-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000155837019010818/0001558370-19-010818-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1641640/000155837020002547/0001558370-20-002547-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000155837020006259/0001558370-20-006259-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000155837020009633/0001558370-20-009633-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000155837020009653/0001558370-20-009653-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1641640/000155837020012839/0001558370-20-012839-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1641640/000155837020012847/0001558370-20-012847-index.htm |
| 2018-08-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000161577418007607/0001615774-18-007607-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000161577419002502/0001615774-19-002502-index.htm |
| 2019-08-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1641640/000161577419011241/0001615774-19-011241-index.htm |
| 2020-09-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1641640/999999999520002426/9999999995-20-002426-index.htm |
| 2018-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1641640/999999999718007156/9999999997-18-007156-index.htm |
| 2018-11-29 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1641640/999999999718009158/9999999997-18-009158-index.htm |
| 2019-03-25 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1641640/999999999719001943/9999999997-19-001943-index.htm |
| 2020-02-06 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1641640/999999999720000557/9999999997-20-000557-index.htm |
| 2020-02-19 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1641640/999999999720000793/9999999997-20-000793-index.htm |
Nabriva Therapeutics plc (NBRV) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nabriva Therapeutics plc (NBRV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 45%Institutional Ownership: 2073%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-08-27 | Theodore R Schroeder | Chief Executive Officer | Buy | 50,000.00 | 1.79 | 89,500.00 | 117,489.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047723/0001104659-19-047723-index.htm |
| 2019-08-19 | Colin MD Broom | Director | Buy | 33,750.00 | 135,901.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046857/0001104659-19-046857-index.htm | ||
| 2019-08-19 | Francesco Maria Lavino | Chief Commercial Officer | Buy | 11,250.00 | 14,969.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046855/0001104659-19-046855-index.htm | ||
| 2020-02-06 | Jennifer Schranz | Chief Medical Officer | Buy | 105,000.00 | 158,705.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015178/0001104659-20-015178-index.htm | ||
| 2019-08-22 | Francesco Maria Lavino | Chief Commercial Officer | Buy | 4,800.00 | 2.04 | 9,780.00 | 15,972.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919047352/0001104659-19-047352-index.htm |
| 2020-07-29 | Carrie L. Bourdow | Director | Buy | 17,500.00 | 17,500.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089144/0001104659-20-089144-index.htm | ||
| 2020-02-06 | Francesco Maria Lavino | Chief Commercial Officer | Buy | 105,000.00 | 180,830.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015173/0001104659-20-015173-index.htm | ||
| 2020-02-06 | Gary Sender | Chief Financial Officer | Buy | 105,000.00 | 183,669.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015174/0001104659-20-015174-index.htm | ||
| 2020-02-06 | Robert Crotty | Gen Counsel & Corp Secretary | Buy | 105,000.00 | 188,097.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015171/0001104659-20-015171-index.htm | ||
| 2020-08-19 | Francesco Maria Lavino | Chief Commercial Officer | Buy | 11,250.00 | 189,884.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097719/0001104659-20-097719-index.htm | ||
| 2020-08-19 | Robert Crotty | Gen Counsel & Corp Secretary | Buy | 11,250.00 | 208,669.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097718/0001104659-20-097718-index.htm | ||
| 2019-08-30 | Colin MD Broom | Director | Buy | 10,177.00 | 2.03 | 20,668.47 | 208,750.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919048436/0001104659-19-048436-index.htm |
| 2020-08-19 | Gary Sender | Chief Financial Officer | Buy | 11,250.00 | 210,180.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097716/0001104659-20-097716-index.htm | ||
| 2019-08-19 | Gary Sender | Chief Financial Officer | Buy | 11,250.00 | 22,604.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046858/0001104659-19-046858-index.htm | ||
| 2020-07-29 | Colin MD Broom | Director | Buy | 17,500.00 | 226,250.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089136/0001104659-20-089136-index.htm | ||
| 2020-08-20 | Colin MD Broom | Director | Sell | 11,064.00 | 0.65 | 7,165.05 | 248,936.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097717/0001104659-20-097717-index.htm |
| 2020-07-29 | Stephen W Webster | Director | Buy | 17,500.00 | 25,500.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089143/0001104659-20-089143-index.htm | ||
| 2020-08-19 | Colin MD Broom | Director | Buy | 33,750.00 | 260,000.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097717/0001104659-20-097717-index.htm | ||
| 2019-08-19 | Robert Crotty | Gen Counsel & Corp Secretary | Buy | 11,250.00 | 27,036.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046856/0001104659-19-046856-index.htm | ||
| 2020-02-06 | Steven P. Gelone | President & COO | Buy | 155,000.00 | 326,919.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015176/0001104659-20-015176-index.htm | ||
| 2019-08-19 | Steven P. Gelone | President and COO | Buy | 11,250.00 | 33,776.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046854/0001104659-19-046854-index.htm | ||
| 2020-08-19 | Steven P. Gelone | President and COO | Buy | 11,250.00 | 352,199.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097720/0001104659-20-097720-index.htm | ||
| 2018-07-31 | DANIEL D BURGESS | Director | Buy | 36,000.00 | 2.75 | 99,000.00 | 36,000.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465918049250/0001104659-18-049250-index.htm |
| 2020-08-19 | Steven P. Gelone | President and COO | Buy | 16,000.00 | 368,199.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920097720/0001104659-20-097720-index.htm | ||
| 2018-07-31 | George Harrison Talbot | Director | Buy | 14,500.00 | 2.75 | 39,875.00 | 47,640.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465918049251/0001104659-18-049251-index.htm |
| 2018-12-24 | Charles A Jr Rowland | Director | Buy | 53,000.00 | 1.31 | 69,430.00 | 53,000.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465918074905/0001104659-18-074905-index.htm |
| 2020-07-29 | DANIEL D BURGESS | Director | Buy | 17,500.00 | 53,500.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089139/0001104659-20-089139-index.htm | ||
| 2019-08-19 | Steven P. Gelone | President and COO | Buy | 16,000.00 | 55,776.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919046854/0001104659-19-046854-index.htm | ||
| 2020-02-06 | Theodore R Schroeder | Chief Executive Officer | Buy | 343,800.00 | 646,560.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920015172/0001104659-20-015172-index.htm | ||
| 2020-07-29 | George Harrison Talbot | Director | Buy | 17,500.00 | 65,140.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089140/0001104659-20-089140-index.htm | ||
| 2019-07-25 | Theodore R Schroeder | Chief Executive Officer | Buy | 6,748.00 | 67,489.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465919041878/0001104659-19-041878-index.htm | ||
| 2020-07-29 | Charles A Jr Rowland | Director | Buy | 17,500.00 | 70,500.00 | https://www.sec.gov/Archives/edgar/data/1641640/000110465920089141/0001104659-20-089141-index.htm |